TABLE 2—
Results of Analysis of Potential Cost-Effectiveness of School-Based Eating Disorder Screening
| Variable | Screen (95% CI) | No Screen (95% CI) |
| Cost per child, $ | 3971 (3579, 4479) | 1710 (1473, 2020) |
| QALYs per child | 8.40 (8.39, 8.41) | 8.36 (8.35, 8.37) |
| LY with ED per child | ||
| Any ED | 0.91 (0.87, 0.95) | 1.16 (1.11, 1.21) |
| Anorexia | 0.11 (0.10, 0.13) | 0.46 (0.43, 0.49) |
| Bulimia | 0.21 (0.19, 0.23) | 0.22 (0.20, 0.24) |
| Binge-eating disorder | 0.31 (0.28, 0.34) | 0.30 (0.28, 0.33) |
| OSFED | 0.28 (0.25, 0.30) | 0.17 (0.17, 0.18) |
| LY recovered from ED per child | ||
| Any ED | 0.51 (0.48, 0.54) | 0.26 (0.24, 0.28) |
| Anorexia | 0.04 (0.03, 0.05) | 0.10 (0.09, 0.11) |
| Bulimia | 0.09 (0.08, 0.10) | 0.04 (0.03, 0.05) |
| Binge-eating disorder | 0.20 (0.17, 0.22) | 0.11 (0.10, 0.13) |
| OSFED | 0.18 (0.16, 0.20) | 0.005 (0.002, 0.008) |
| Time spent in treatment, y | ||
| Standard therapy | 0.95 (0.90, 1.0) | 0.25 (0.24, 0.27) |
| Low-intensity therapy | 0.33 (0.31, 0.35) | 0.02 (0.02, 0.02) |
| Net mean cost, $ | 2260 (1892, 2668) | |
| Net mean difference in LY with ED, y | −0.25 (−0.30, −0.21) | |
| Net mean difference in QALYs | 0.04 (0.03, 0.05) | |
| Incremental cost-effectiveness ratio (ICER; net costs per net benefits) | ||
| ICER LY with ED avoided, $/LY | 9041 (6617, 12 344) | |
| ICER QALY gained, $/QALY | 56 500 (38 805, 71 250) |
Note. CI = confidence interval; ED = eating disorder; ICER = incremental cost-effectiveness ratio; LY = life-years; OSFED = other specified feeding or eating disorder; QALY = quality-adjusted life-year. Numbers may not add up perfectly because of rounding.